Articles by Rachel Lutz - Page 4

Latest Articles

Fidaxomicin Effective for Patients Experiencing First C. difficile Infection Episode
  |  Rachel Lutz
Patients using fidaxomicin for C diff infection experienced no recurrences..
Non-Frozen Oral Capsules Could be Next Step in C. difficile Treatment
  |  Rachel Lutz
Researchers, for the first time, used the lyophilized non-frozen oral capsule RBX7455 to treat a patient with recurrent Clostridium difficile (C. difficile) infection.
Central Sleep Apnea a Problem for Multiple Sclerosis Patients
  |  Rachel Lutz
People with multiple sclerosis tend to have sleep apnea, but not the usual kind, a study found.
Updating Diagnostics, Attitudes, and Treatments Surrounding Borderline Personality Disorder
  |  Rachel Lutz
There is an urgent need to improve diagnostic abilities and management of borderline personality disorder, despite significant breakthroughs.
Multiple Sclerosis Associated with Disruption of Microbiome
  |  Rachel Lutz
Looking at post-mortem brain samples, researchers found that multiple sclerosis is associated with an abundance of bacteria and molecular diversity.
FMT Is Not a Cure-All
  |  Rachel Lutz
While effective for Clostridium difficile (C. difficile) infection in irritable bowel syndrome (IBS) patients, fecal microbiota transplants did not relieve the IBS itself.
Multiple Sclerosis: Neural Stem Cells Hold Key to New Therapies?
  |  Rachel Lutz
Finding neural stem cells in the brain’s meninges could lead to new therapies for multiple sclerosis patients.
Alemtuzumab Treatment Better Alleviates Disability in Multiple Sclerosis Patients than Interferon Beta 1a
  |  Rachel Lutz
Alemtuzumab was more beneficial to patients with relapsing remitting multiple sclerosis than subcutaneous interferon beta 1a in various measures of preexisting disability.
Scientists Review Efficacy of Off-Label C. difficile Treatments
  |  Rachel Lutz
Many off label therapeutic options currently exist for treating Clostridium difficile (C. difficile) infection, but combinations of these choices can develop into viable, approved treatments, according to a recently published product review.

Most Popular


$vacMongoViewPlus$ $vAR$